Tocotrienol: a review of its therapeutic potential

Kamal-Eldin, 1996, The chemistry and antioxidant properties of tocopherols and tocotrienols, Lipids, 31, 671, 10.1007/BF02522884 Meydani, 1995, Vitamin E, Lancet, 345, 170, 10.1016/S0140-6736(95)90172-8 Ames, 1995, The cause and prevention of cancer, Proc Natl Acad Sci USA, 2, 5258, 10.1073/pnas.92.12.5258 Combs, 1992 Hood, 1996, Tocotrienols and cholesterol metabolism, 96 Carroll KK, Cuthrie N, Nesaretnam K, Gapor A, Chambers AF. Anti-cancer properties of tocotrienols from palm oil. In: Ong ASH, Niki E, Packer L, Eds. Nutrition, lipids, health, and disease. Pp. 117–21. Champaign, IL: AOCS Press, 1996. 1998 Heart and Stroke Statistical Update. American Heart Association (1997), Dallas. 1984, The lipid research clinics coronary primary prevention trial results I, JAMA, 251, 351, 10.1001/jama.251.3.351 National Center for Health Statistics (NCHS). Annual summary of births, marriages, divorces, and deaths: United States, 1990. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, CDC, 1991. (Monthly vital statistics report: 39(13).) Stampfer, 1993, Vitamin E consumption and the risk of coronary disease in women, N Engl J Med, 328, 1444, 10.1056/NEJM199305203282003 Rimm, 1993, Vitamin E consumption and the risk of coronary heart disease in man, N Engl J Med, 328, 1450, 10.1056/NEJM199305203282004 Hodis, 1995, Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis, JAMA, 273, 1849, 10.1001/jama.273.23.1849 Kushi, 1996, Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women, N Engl J Med, 334, 1156, 10.1056/NEJM199605023341803 Stephens, 1996, Randomized controlled trial of vitamin E in patients with coronary disease, Lancet, 347, 781, 10.1016/S0140-6736(96)90866-1 Esterbauer, 1991, Role of vitamin E in preventing the oxidation of low-density lipoprotein, Am J Clin Nutr, 3, 314S, 10.1093/ajcn/53.1.314S Salonen, 1992, Autoantibody against oxidized LDL and progression of carotid atherosclerosis, Lancet, 339, 883, 10.1016/0140-6736(92)90926-T Salonen, 1985, Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease, Am J Cardiol, 56, 226, 10.1016/0002-9149(85)90839-2 Kok, 1987, Serum selenium, vitamin antioxidants and cardiovascular mortality, Am J Clin Nutr, 45, 462, 10.1093/ajcn/45.2.462 Hense, 1993, Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels, Atherosclerosis, 103, 21, 10.1016/0021-9150(93)90036-T Qureshi, 1991, Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee), Am J Clin Nutr, 53, 1021S, 10.1093/ajcn/53.4.1021S Qureshi, 1995, Response of hypercholesterolemic subjects to administration of tocotrienols, Lipids, 30, 1171, 10.1007/BF02536620 Qureshi, 1997, Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans, Nutr Biochem, 8, 290, 10.1016/S0955-2863(97)89667-2 Tomeo, 1995, Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis, Lipids, 30, 1179, 10.1007/BF02536621 Qureshi, 1986, The structure of an inhibitor of cholesterol biosynthesis isolated from barley, J Biol Chem, 261, 10544, 10.1016/S0021-9258(18)67419-8 Goldstein, 1990, Regulation of the mevalonate pathway, Nature, 343, 425, 10.1038/343425a0 Correll, 1994, Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, J Biol Chem, 269, 17390, 10.1016/S0021-9258(17)32450-X Qureshi, 1991, Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias, Am J Clin Nutr, 53, 1042S, 10.1093/ajcn/53.4.1042S Pearce, 1992, Hypocholesterolemic activity of synthetic and natural tocotrienols, J Med Chem, 35, 3595, 10.1021/jm00098a002 Pearce, 1992, Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydroaphthalene analogues of the tocotrienols, J Med Chem, 37, 526, 10.1021/jm00030a012 Qureshi, 1996, Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens, J Nutr, 126, 389, 10.1093/jn/126.2.389 Albers, 1989, Apoprotein measurements and their clinical application in cholesterol screening, Clin Lab Med, 34, B4 Sniderman, 1980, Association of coronary atherosclerosis with hyperbetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low-density (beta) lipoproteins], Proc Natl Acad Sci USA, 77, 604, 10.1073/pnas.77.1.604 Brown, 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B, N Engl J Med, 323, 1289, 10.1056/NEJM199011083231901 Bestehorn, 1997, The effect of simvastatin on progression of coronary artery disease, Eur Heart J, 18, 226, 10.1093/oxfordjournals.eurheartj.a015224 Parker, 1993, Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-Hydroxy-3-methylglutaryl-coenzyme A reductase, J Biol Chem, 268, 11230, 10.1016/S0021-9258(18)82115-9 Wang, 1998, Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B, Biochem Biophys Res Commun, 246, 640, 10.1006/bbrc.1998.8677 Theriault, 1999, Effects of γ-tocotrienol on apolipoprotein B synthesis, degradation, and secretion in HepG2 cells, Arterioscler Thromb Vasc Biol, 19, 704, 10.1161/01.ATV.19.3.704 Maher, 1995, Lipoprotein(a) and coronary heart disease, Curr Opin Lipidol, 6, 229, 10.1097/00041433-199508000-00007 Scanu, 1990, Lipoprotein(a), J Clin Invest, 86, 1709, 10.1172/JCI114625 Naruszewicz, 1992, Oxidative modification of lipoprotein(a) and the effect of β-carotene, Metabolism, 41, 1215, 10.1016/0026-0495(92)90012-Y McLean, 1987, cDNA sequence of human apolipoprotein(a) is homologous to plasminogen, Nature, 330, 132, 10.1038/330132a0 Miles, 1989, A potential basis for the thrombotic risks associated with lipoprotein(a), Nature, 339, 301, 10.1038/339301a0 Yamaguchi, 1994, Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA), Chem Phys Lipids, 67/68, 399, 10.1016/0009-3084(94)90162-7 Kanemitsu, 1994, Effects of LDL apheresis on restenosis after angioplasty, Chem Phys Lipids, 67/68, 339, 10.1016/0009-3084(94)90155-4 Jenner, 1993, Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels, Circulation, 87, 607, 10.1161/01.CIR.87.4.1135 Brewer HB. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In: Scanu AM. Ed. Lipoprotein(a). Pp. 211–20. New York: Academic Press, 1990. Carlson, 1989, Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid, J Intern Med, 226, 271, 10.1111/j.1365-2796.1989.tb01393.x Pelegri, 1992, Effect of bezafibrate on lipoprotein(a) and triglyceride-rich lipoproteins, including intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysis, Nephrol Dial Transplant, 7, 623, 10.1093/ndt/7.7.623 Farmer, 1995, Currently available hypolipidaemic drugs and future therapeutic developments, Baillieres Clin Endocrinol Metab, 9, 825, 10.1016/S0950-351X(95)80177-4 Hirsh, 1987, Hyperactive platelets and complications of coronary artery disease, N Engl J Med, 316, 1543, 10.1056/NEJM198706113162410 Jandak, 1989, α-Tocopherol, an effective inhibitor of platelet adhesion, Blood, 73, 141, 10.1182/blood.V73.1.141.141 Romach, 1993, Effects of RRR-alpha-tocopheryl succinate on IL-1 and PGE2 production by macrophages, Nutr Cancer, 20, 205, 10.1080/01635589309514288 Meydani, 1993, Modulation by dietary vitamin E and selenium of clotting whole blood thromboxane A2 and aortic prostacyclin synthesis in rats, Nutr Biochem, 4, 322, 10.1016/0955-2863(93)90076-9 Douglas, 1986, Vitamin E inhibits platelet phospholipase A2, Biochem Biophys Acta, 876, 639, 10.1016/0005-2760(86)90053-6 Traber, 1995, Vitamin E, Am J Clin Nutr, 62, 1501S, 10.1093/ajcn/62.6.1501S Appleby, 1994, Structure of the human cyclo-oxygenase-2 gene, Biochem J, 302, 723, 10.1042/bj3020723 Steiner, 1995, Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks, Am J Clin Nutr, 62, 1381S, 10.1093/ajcn/62.6.1381S Niki, 1985, Effect of phytyl side chain of vitamin E on its antioxidant activity, J Biol Chem, 260, 2191, 10.1016/S0021-9258(18)89536-9 Burton, 1989, Vitamin E as in vitro and in vivo antioxidant, Ann NY Acad Sci, 570, 7, 10.1111/j.1749-6632.1989.tb14904.x Burton, 1990, Vitamin E, Ann Rev Nut, 10, 357, 10.1146/annurev.nu.10.070190.002041 Steinberg, 1989, Beyond cholesterol, N Engl J Med, 320, 915, 10.1056/NEJM198904063201407 Verlangeri, 1992, Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis, J Am Coll Nutr, 11, 131, 10.1080/07315724.1992.12098234 Reaven, 1993, Effect of dietary antioxidant combinations in humans, Arterioscler Thromb, 13, 590, 10.1161/01.ATV.13.4.590 Burton, 1983, Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?, Arch Biochem Biophys, 221, 281, 10.1016/0003-9861(83)90145-5 Cooney, 1993, γ-Tocopherol detoxification of nitrogen dioxide, Proc Natl Acad Sci USA, 90, 1771, 10.1073/pnas.90.5.1771 Serbinova, 1991, Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol, Free Radic Biol Med, 10, 263, 10.1016/0891-5849(91)90033-Y Suzuki, 1993, Structural and dynamic membrane properties of α-tocopherol and α-tocotrienol, Biochemistry, 32, 10692, 10.1021/bi00091a020 Kamat, 1995, Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria, Neuro Lett, 195, 179, 10.1016/0304-3940(95)11812-B Serbinova, 1992, Palm oil vitamin E protects against ischemia/reperfusion injury in the isolated perfused Langendorff heart, Nutr Res, 12, S203, 10.1016/S0271-5317(05)80464-6 Carlos, 1994, Leukocyte-Endothelial adhesion molecules, Blood, 84, 2068, 10.1182/blood.V84.7.2068.2068 Peter, 1997, Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin, Arterioscler Thromb Vasc Biol, 17, 505, 10.1161/01.ATV.17.3.505 Blann, 1994, Circulating endothelial cell leukocyte adhesion molecules in atherosclerosis, Thromb Haemost, 74, 151 Schreck, 1992, Nuclear factor κB, Free Radic Res Commun, 17, 221, 10.3109/10715769209079515 Khan, 1995, Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells, J Clin Invest, 95, 1262, 10.1172/JCI117776 Cominacini, 1997, Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidizied LDL on human umbilical vein endothelial cells, Free Radic Biol Med, 22, 117, 10.1016/S0891-5849(96)00271-7 Devaraj, 1996, The effects of alpha tocopherol supplementation on monocyte function, J Clin Invest, 98, 756, 10.1172/JCI118848 Birt, 1986, Update on the effects of vitamin A, C and E, and selenium on carcinogenesis, Proc Soc Exp Biol Med, 183, 311, 10.3181/00379727-183-42424 Bostick, 1993, Reduced risk of colon cancer with high intake of vitamin E, Cancer Res, 53, 4230 Taylor, 1994, Prevention of eosophageal cancer, Cancer Res, 54, 2029S 1994, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, N Engl J Med, 330, 1029, 10.1056/NEJM199404143301501 Ames, 1999, Infection, inflammation and mutation, 28 Serbinova, 1993, Antioxidant action of α-tocopherol and α-tocotrienol in membranes, 235 Watkins, 1993, γ-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets, Lipids, 28, 1113, 10.1007/BF02537079 Komiyama, 1989, Studies on the biological activity of tocotrienols, Chem Pharm Bull, 37, 1369, 10.1248/cpb.37.1369 Wan Ngah, 1991, Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats, Am J Clin Nutr, 53, 1076S, 10.1093/ajcn/53.4.1076S Rahmat, 1993, Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats, Nutrition, 9, 229 Nesaretnam, 1995, Effect of tocotrienols on the growth of a human breast cancer cell line in culture, Lipids, 30, 1139, 10.1007/BF02536615 Guthrie, 1997, Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination, J Nutr, 127, 544S, 10.1093/jn/127.3.544S Nesaretnam, 1998, Tocotrienols inhibit the growth of human breast cancer cells irrespectively of estrogen receptor status, Lipids, 33, 461, 10.1007/s11745-998-0229-3 Turley, 1992, RRR-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation, Nutr Cancer, 18, 201, 10.1080/01635589209514221 Charpentier, 1993, RRR-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells, Nutr Cancer, 19, 225, 10.1080/01635589309514254 Crowell, 1991, Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites, J Biol Chem, 266, 17679, 10.1016/S0021-9258(19)47425-5 Elson, 1994, The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables, J Nutr, 124, 607, 10.1093/jn/124.5.607 Larner, 1998, A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme, Am J Clin Oncol, 21, 579, 10.1097/00000421-199812000-00010 Stone, 1997, Tocopherols and the etiology of colon cancer, J Natl Cancer Inst, 89, 1006, 10.1093/jnci/89.14.1006 Christen, 1997, γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol, Proc Natl Acad Sci USA, 94, 3217, 10.1073/pnas.94.7.3217 Packer, 1979, Direct observation of a free radical interaction between vitamin E and vitamin C, Nature, 278, 737, 10.1038/278737a0 Gould, 1991, A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors, Am J Clin Nutr, 53, 1068S, 10.1093/ajcn/53.4.1068S